Association of biomarkers (BMs) with efficacy of adjuvant nivolumab (NIVO) vs placebo (PBO) in patients with resected stage IIB/C melanoma (CA209-76K).
暂无分享，去创建一个
J. Taube | J. Kirkwood | M. Del Vecchio | Hao Tang | J. Grob | V. Chiarion-Sileni | G. Long | C. Loquai | J. Weber | S. Dolfi | P. Mohr | C. Hoeller | C. Dutriaux | D. Tenney | B. Gastman | A. V. van Akkooi | C. Ritchings | F. Campigotto | M. Lobo | Wenjia Wang